Skip to main content
. 2021 Jan 22;16(1):e0245565. doi: 10.1371/journal.pone.0245565

Table 3. Medications before PE diagnosis.

Total (n = 333) PE (n = 109) Non-PE (n = 224) p
Aspirin 45 (14%) 13 (12%) 32 (15%) 0.55
Clopidogrel 11 (3%) 2 (2%) 9 (4%) 0.51
Warfarin 9 (3%) 4 (4%) 5 (2%) 0.48
DOAC 17 (5%) 11 (10%) 6 (3%) 0.004
LMWH (prophylactic dose) 223 (67%) 66 (61%) 157 (70%) 0.08
Hydroxychloroquine 281 (84%) 88 (81%) 193 (86%) 0.2
Tocilizumab 16 (5%) 5 (5%) 11 (5%) 0.9

Data are n (%).

PE: pulmonary embolism; DOAC: direct-acting oral anticoagulants; LMWH: low molecular weight heparin.